Other soluble molecules, such as transforming growth factor-beta1 (TGF-β), may also have remarkable repressive impacts [40], and sera isolated from AML patients have been reported to include micro-vesicles carrying TGF-β at their surface, which can induce a change in NK cell activity. The gene discussed is TGFB1; the disease is acute myeloid leukemia.